bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · Real-Time Price · USD
0.499
-0.014 (-2.65%)
At close: Oct 24, 2024, 4:00 PM
0.500
+0.001 (0.18%)
After-hours: Oct 24, 2024, 5:08 PM EDT

bluebird bio Revenue

bluebird bio had revenue of $16.10M in the quarter ending June 30, 2024, with 133.69% growth. This brings the company's revenue in the last twelve months to $54.90M, up 483.79% year-over-year. In the year 2023, bluebird bio had annual revenue of $29.50M with 720.04% growth.

Revenue (ttm)
$54.90M
Revenue Growth
+483.79%
P/S Ratio
1.43
Revenue / Employee
$146,400
Employees
375
Market Cap
96.78M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202329.50M25.90M720.04%
Dec 31, 20223.60M-65.00K-1.77%
Dec 31, 20213.66M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 206.62M
Agenus 159.63M
Assertio Holdings 132.19M
FONAR 102.88M
DBV Technologies 13.81M
Revenue Rankings